Skip to main content

Clinical Trials Day

Clinical Trials Day, celebrated on May 20th, is an opportunity to recognize and show appreciation to clinical research professionals for their efforts in improving public health. 

Join us in celebrating Clinical Trials Day 2023 with blogs, featured articles, and collections from BMC Trials.

If you are interested in publishing clinical trials research, please consider submitting your manuscript to the latest collection in our Trials journal: Case studies of experience with interim data and IDMCs in RCTs

Clinical Trials Research

Featured Blogs

International Clinical Trials Methodology Conference (ICTMC) 2022

In this blog for Clinical Trials Day 2023, Claire Veryard (Programme Manager for the ISRCTN registry) shares some highlights and learning from the International Clinical Trials Methodology Conference (ICTMC) held in October 2022.

Read More

Clinical Trials Day 2023: what about the trial participant?

In this blog for Clinical Trials Day 2023, Derek C Stewart OBE, a non-executive director at the ISRCTN registry, discusses the importance of patient and public involvement in clinical trials.

Read More

Structured reporting of study protocols

In this blog for Clinical Trials Day 2022, we reflect on the Trials journal Structured Study Protocol Template project since its launch in 2019.

Read More

COVID-19 structured summaries: rapid publication of randomised trial protocols in BMC Trials

In response to the COVID-19 pandemic, rapid sharing of information about planned clinical trials investigating treatments and vaccines was necessary. In this blog for Clinical Trials Day 2021, we look at the novel reporting of study protocols of COVID-19 randomised trials through the BMC Trials structured summary project over the past year. 

Read More

Welcoming Submissions

Call for papers: Case studies of experience with interim data and IDMCs in RCTs

Trials invites submission of manuscripts setting out examples of interim (and final) data and the decisions that were made, and of reactions to IDMC recommendations. IDMC members are not co-authors on trial results papers or protocol papers because this compromises their independence; however, co-authorship would be encouraged for these manuscripts to ensure that insight is captured from all parties. If necessary, Trials could explore how to blind individual trials where sharing lessons could be problematic. These case studies would be intended as Commentaries.

Read More

Browse our General Medicine and Medical Evidence Journals